Impact of the Development of Pediatric Palliative Care

Last updated: December 7, 2023
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Glioblastoma Multiforme

Astrocytoma

Treatment

N/A

Clinical Study ID

NCT05660499
8137
  • Ages 1-17
  • All Genders

Study Summary

Despite medical advances, cancer remains the leading cause of death by disease in children.

Brain tumors are the second most common cause of cancer in children after leukemia, representing 25% of pediatric cancers.

The overall survival rate is about 50% with extremes ranging from less than 5% to more than 90% depending on the histological type of brain tumor.

The end of life of children with a brain tumor is marked by the possibility of discomfort symptoms, painful or not, and by a progressive neurological deterioration, which makes the management of these children complex for both families and health professionals.

Over the last decade, the concept of palliative care has been increasingly integrated into pediatric onco-hematology services with the primary objective of better symptom control in a global approach to the child and his or her family in order to aim at a better quality of life.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • Patient less than 17 years of age
  • Suffering from a primary brain tumor
  • Died during the period 2009-2010 or during the period 2019-2020
  • Follow-up in one of the Pediatric Oncology departments participating in the study (Strasbourg, Besançon, Dijon, Nancy and Reims)
  • Absence of refusal expressed in the medical file by the parents or the holder(s) ofparental authority concerning the reuse of the child's personal data for researchpurposes.

Exclusion

Exclusion criteria:

  • Refusal expressed in the medical file by the parents or the holder(s) of parentalauthority concerning the reuse of the child's personal data for research purposes
  • Patient with a brain tumor secondary to another cancer

Study Design

Total Participants: 40
Study Start date:
February 15, 2021
Estimated Completion Date:
December 31, 2023

Study Description

The main objective of the study is to compare the occurrence and management of end-of-life symptoms in children who died of a primary brain tumor over 2 periods, in 2009 - 2010 and in 2019 - 2020, followed in the Pediatric Oncology departments of Strasbourg, Besançon, Dijon, Nancy and Reims.

Connect with a study center

  • Service de soins Palliatifs - CHU de Strasbourg - France

    Strasbourg, 67091
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.